SARS-CoV-2-specific T cells exhibit phenotypic features reflecting helper function, lack of terminal differentiation, and high proliferation potential
Data files
Jun 25, 2020 version files 430.21 MB
-
PID4100_singlets_CD4928_CD3_.fcs
29.20 MB
-
PID4100_singlets_CMVP_CD3_.fcs
32.81 MB
-
PID4100_singlets_CovidP_CD3_.fcs
32.02 MB
-
PID4101_singlets_CD4928_CD3_.fcs
31.99 MB
-
PID4101_singlets_CMVP_CD3_.fcs
28.65 MB
-
PID4101_singlets_CovidP_CD3_.fcs
29.38 MB
-
PID4102_singlets_CD4928_CD3_.fcs
15.88 MB
-
PID4102_singlets_CMVP_CD3_.fcs
16.70 MB
-
PID4102_singlets_CovidP_CD3_.fcs
13.81 MB
-
PID4103_singlets_CD4928_CD3_.fcs
27.93 MB
-
PID4103_singlets_CMVP_CD3_.fcs
23.54 MB
-
PID4103_singlets_CovidP_CD3_.fcs
28.80 MB
-
PID4105_singlets_CD4928_CD3_.fcs
19.84 MB
-
PID4105_singlets_CMVP_CD3_.fcs
17.79 MB
-
PID4105_singlets_CovidP_CD3_.fcs
22.04 MB
-
PID4106_singlets_CD4928_CD3_.fcs
17.05 MB
-
PID4106_singlets_CMVP_CD3_.fcs
20.44 MB
-
PID4106_singlets_CovidP_CD3_.fcs
22.35 MB
Nov 09, 2020 version files 1 GB
-
PID4100_singlets_CD4928_CD3_.fcs
29.20 MB
-
PID4100_singlets_CMVP_CD3_.fcs
32.81 MB
-
PID4100_singlets_CovidP_CD3_.fcs
32.02 MB
-
PID4101_singlets_CD4928_CD3_.fcs
31.99 MB
-
PID4101_singlets_CMVP_CD3_.fcs
28.65 MB
-
PID4101_singlets_CovidP_CD3_.fcs
29.38 MB
-
PID4102_singlets_CD4928_CD3_.fcs
15.88 MB
-
PID4102_singlets_CMVP_CD3_.fcs
16.70 MB
-
PID4102_singlets_CovidP_CD3_.fcs
13.81 MB
-
PID4103_singlets_CD4928_CD3_.fcs
27.93 MB
-
PID4103_singlets_CMVP_CD3_.fcs
23.54 MB
-
PID4103_singlets_CovidP_CD3_.fcs
28.80 MB
-
PID4104_singlets_CD4928_CD3_.fcs
26.08 MB
-
PID4104_singlets_CMVP_CD3_.fcs
28.27 MB
-
PID4104_singlets_CovidP_CD3_.fcs
44.67 MB
-
PID4105_singlets_CD4928_CD3_.fcs
19.84 MB
-
PID4105_singlets_CMVP_CD3_.fcs
17.79 MB
-
PID4105_singlets_CovidP_CD3_.fcs
22.04 MB
-
PID4106_singlets_CD4928_CD3_.fcs
17.05 MB
-
PID4106_singlets_CMVP_CD3_.fcs
20.44 MB
-
PID4106_singlets_CovidP_CD3_.fcs
22.35 MB
-
PID4107_singlets_CD4928_CD3_.fcs
13.57 MB
-
PID4107_singlets_CMVP_CD3_.fcs
11.90 MB
-
PID4107_singlets_CovidP_CD3_.fcs
52.22 MB
-
PID4108_singlets_CD4928_CD3_.fcs
10.79 MB
-
PID4108_singlets_CMVP_CD3_.fcs
10.55 MB
-
PID4108_singlets_CovidP_CD3_.fcs
42.29 MB
-
PID4109_singlets_CD4928_CD3_.fcs
8.36 MB
-
PID4109_singlets_CMVP_CD3_.fcs
8.91 MB
-
PID4109_singlets_CovidP_CD3_.fcs
35.31 MB
-
PID4110_singlets_CD4928_CD3_.fcs
39.85 MB
-
PID4110_singlets_CMVP_CD3_.fcs
44.84 MB
-
PID4110_singlets_CovidP_CD3_.fcs
69.07 MB
-
PID4114_singlets_CD4928_CD3_.fcs
33.36 MB
-
PID4114_singlets_CMVP_CD3_.fcs
29.43 MB
-
PID4114_singlets_CovidP_CD3_.fcs
60.71 MB
Abstract
Convalescing COVID-19 patients mount robust T cell responses against SARS-CoV-2, suggesting an important role for T cells in viral clearance. To date, the phenotypes of SARS-CoV-2-specific T cells remain poorly defined. Using 38-parameter CyTOF, we phenotyped longitudinal specimens of SARS-CoV-2-specific CD4+ and CD8+ T cells from nine individuals who recovered from mild COVID-19. SARS-CoV-2-specific CD4+ T cells were exclusively Th1 cells, and predominantly Tcm with phenotypic features of robust helper function. SARS-CoV-2-specific CD8+ T cells were predominantly Temra cells in a state of less terminal differentiation than most Temra cells. Subsets of SARS-CoV-2-specific T cells express CD127, can homeostatically proliferate, and can persist for over two months. Our results suggest that long-lived and robust T cell immunity is generated following natural SARS-CoV-2 infection, and support an important role for SARS-CoV-2-specific T cells in host control of COVID-19.